Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at raps@raps.org if you need assistance.
The regulatory function is vital in making safe and effective healthcare products available worldwide. Individuals who ensure regulatory compliance and prepare submissions, as well as those whose main job function is clinical affairs or quality assurance are all considered regulatory professionals.
Resources, news and special offers to support you and your professional development during this difficult time.
One of our most valuable contributions to the profession is the Regulatory Code of Ethics. The Code of Ethics provides regulatory professionals with core values that hold them to the highest standards of professional conduct.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Like all professions, regulatory is based on a shared set of competencies. The Regulatory Competency Framework describes the essential elements of what is required of regulatory professionals at four major career and professional levels.
Download your copy of the new events calendar and see all the online workshops, conferences, RAC exams and European online workshops RAPS has planned for 2021 at a glance.
Registration is now open for RAPS Euro Convergence 2021! Attend to join peers from EU and around the world to gain insights and exchange ideas on the regions most pressing issues.
An invaluable resource for any professional engaged in designing, composing, compiling, or commenting on regulatory documentation
From self-assessments to help you identify your strengths and areas to focus on to reference books and online courses that will help you fill in the gaps in your regulatory knowledge, RAPS has the resources to help you prepare for the RAC exam.
The site navigation utilizes arrow, enter, escape, and space bar key commands. Left and right arrows move across top level links and expand / close menus in sub levels. Up and Down arrows will open main level menus and toggle through sub tier links. Enter and space open menus and escape closes them as well. Tab will move on to the next part of the site rather than go through menu items.
Posted 14 August 2012 | By Alexander Gaffney, RAC
The US Food and Drug Administration (FDA) has approved a new medical device, largely unremarkable but for one unusual aspect: It gives instructions to its administrator verbally.
French life sciences manufacturer Sanofi said its Auvi-Q (epinephrine injection, USP) auto-injector had received FDA approval on 13 August 2012. The device is used in patients who are at risk for or have a history of going into anaphylactic shock as the result of an allergic reaction.
The device is used by many patients on themselves, but is also relatively unusual in that the medical circumstances surrounding the event may require a non-physician caregiver-including a stranger-to administer the epinephrine injection on behalf of the patient in an emergency situation.
Sanofi said its Auvi-Q device improves this less-than-ideal situation by talking the user through each step of the administration process, easing the concerns of patients concerned the auto-injectors will be used incorrectly. Sanofi noted the device also features an auto-retractable needle to prevent accidental needle sticks, which are a potential problem for those not used to handling similar devices.
"In the event of a life-threatening allergic reaction, it's important to know how to respond quickly," explained Dr. Vivian Hernandez-Trujillo, a pediatric allergist, in a statement provided by Sanofi. "Auvi-Q offers patients and caregivers guidance through the injection process."
Sanofi noted the device is the first portable epinephrine auto-injector to contain the instruction feature, though similar features are available on automated external defibrillators (AEDs).
Tags: Instruction for Use, Verbal, Auto-Injector, IFU, Latest News, medical device
Regulatory Focus newsletters
All the biggest regulatory news and happenings.